Seeking Alpha had a good piece Sunday on the poor performance of China's biomedical industry when it comes to venture capital funding.

The comparison is simple enough. In the U.S., biomedical projects rake in 31% of all venture capital funding. In China, only 2.4% of venture capital funding went to biomedical and/or healthcare projects in the recently released Q2 numbers.

Everyone keeps waiting and predicting that the biomedical take of VC funds in China will start to climb. So far it hasn't...


© Patrick J. Lynch